Rang	Name	Position
1	Mr. Geoffrey Straub Martha	Chairman of the Board & CEO
2	Mr. Thierry Pieton	Executive VP & CFO
3	Mr. Brett A. Wall	Executive Officer
4	Mr. Rogerio Branco	SVP & Chief Operations and Supply Chain Officer
5	Ms. Denise L. Blomquist	VP, Global Controller & Chief Accounting Officer
6	Dr. Laura Mauri M.D., M.Sc.	Senior VP and Chief Scientific & Medical Officer
7	Ms. Ingrid Goldberg	Vice President & Head of Investor Relations
8	Ms. Michelle Quinn	Executive VP, General Counsel & Secretary
9	Mr. Matthew R. Walter	Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing
10	Mr. Jason Weidman	Senior VP and President of Coronary & Renal Denervation business

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	10,07%	11,20 Mrd. USD
2	BlackRock Inc	8,84%	9,83 Mrd. USD
3	Vanguard Capital Management, LLC	6,51%	7,24 Mrd. USD
4	State Street Corp	4,82%	5,36 Mrd. USD
5	JPMorgan Chase & Co	3,98%	4,43 Mrd. USD
6	Capital Research Global Investors	3,28%	3,64 Mrd. USD
7	Vanguard Portfolio Management, LLC	2,61%	2,91 Mrd. USD
8	Geode Capital Management, LLC	2,24%	2,50 Mrd. USD
9	Bank of America Corp	2,03%	2,26 Mrd. USD
10	Massachusetts Financial Services Company	1,67%	1,86 Mrd. USD
11	Morgan Stanley - Brokerage Accounts	1,62%	1,80 Mrd. USD
12	Deutsche Bank AG	1,48%	1,65 Mrd. USD
13	NORGES BANK	1,34%	1,50 Mrd. USD
14	Amvescap Plc.	1,31%	1,46 Mrd. USD
15	Capital World Investors	1,29%	1,43 Mrd. USD
16	Bank of New York Mellon Corp	1,21%	1,35 Mrd. USD
17	Royal Bank of Canada	1,11%	1,23 Mrd. USD
18	Franklin Resources Inc	1,11%	1,23 Mrd. USD
19	Northern Trust Corp	0,94%	1,05 Mrd. USD
20	Ameriprise Financial Inc	0,94%	1,04 Mrd. USD